Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Insmed Inc (NASDAQ:INSM)

13.94
Delayed Data
As of Sep 29
 -0.72 / -4.91%
Today’s Change
9.02
Today|||52-Week Range
21.14
-23.20%
Year-to-Date
Institutional investors purchased a net $507.2 thousand shares of INSM during the quarter ended June 2016 and now own 92.01% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders56.78%
Individual stakeholders5.23%
Other institutional35.23%

Largest Quarterly Institutional
Transactions

Chart unavailable

Latest Institutional Activity

Top 10 Owners of Insmed Inc

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change

Top 10 Mutual Funds Holding Insmed Inc

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
T Rowe Price Health Sciences Fund6.47%4,005,57251,872,157+227,700+6.03%
Fidelity Select Health Care Portf...4.85%3,000,00038,850,000+129,630+4.52%
T Rowe Price New Horizons Fund3.20%1,978,20025,617,690+172,700+9.57%
Janus Global Life Sciences Fund2.53%1,565,92320,278,703-19,476-1.23%
Fidelity VIP - Growth Portfolio2.13%1,318,40217,073,30600.00%
Vanguard Total Stock Market Index...1.97%1,218,59315,780,77900.00%
T Rowe Price Small Cap Stock Fund1.86%1,147,70014,862,715+88,100+8.31%
Fidelity Advisor Health Care Fund1.78%1,100,00014,245,00000.00%
iShares Russell 2000 ETF1.59%981,23312,706,967-19,580-1.96%
Prudential Jennison Health Scienc...1.39%857,40711,103,42100.00%